Celgene International II Sàrl;Dana-Farber Cancer Institute, Inc.
发明人:
Kenneth C. ANDERSON,Dharminder CHAUHAN,Michael A. PALLADINO
申请号：
US16800570
公开号：
US20200206190A1
申请日:
2020.02.25
申请国别(地区):
US
年份:
2020
代理人:
摘要：
Disclosed herein are compositions and methods for treating neoplastic diseases. Included are compositions and methods that are effective against multiple myeloma cells resistant to conventional and bortezomib treatment. Furthermore, combination treatment with two different proteosome inhibitors is shown to be synergistic for treating multiple myeloma.
